Hodgkin Lymphoma Clinical Trials
Hodgkin Lymphoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for hodgkin Lymphoma. Corterve aggregates actively recruiting Hodgkin Lymphoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Hodgkin Lymphoma studies
- Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell LymphomaNCT03223610PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
- A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin LymphomaNCT05645107PHASE3Grifols Therapeutics LLCHuntington Park, California
- Personalized NK Cell Therapy in CBTNCT02727803PHASE2M.D. Anderson Cancer CenterHouston, Texas
- A Study of ARC-02 in B-cell NHLNCT07691606PHASE1Taiho Oncology, Inc.Los Angeles, California
- CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell MalignanciesNCT05442515PHASE1, PHASE2National Cancer Institute (NCI)Bethesda, Maryland
- IKS03 in Patients With Advanced B Cell Non-Hodgkin LymphomasNCT05365659PHASE1Iksuda Therapeutics Ltd.Baltimore, Maryland
- Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell LymphomaNCT03011814PHASE1, PHASE2City of Hope Medical CenterDuarte, California
- A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin LymphomaNCT05705531Children's Oncology GroupMobile, Alabama
- The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasNCT07285044PHASE2Mayo ClinicJacksonville, Florida
- A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantNCT07020533PHASE1City of Hope Medical CenterDuarte, California
- A Phase 1 of CTX-8371 in Patients With Advanced MalignanciesNCT06150664PHASE1Compass TherapeuticsMargate, Florida
- A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabNCT05675410PHASE3National Cancer Institute (NCI)Birmingham, Alabama
Hodgkin Lymphoma trials by state
Hodgkin Lymphoma trials by metro
Frequently asked questions
- How do I find recruiting Hodgkin Lymphoma clinical trials?
- Corterve aggregates actively recruiting Hodgkin Lymphoma studies from the public ClinicalTrials.gov registry. Browse the studies listed on this page or take a free health assessment to see trials you may qualify for based on your profile.
- Are Hodgkin Lymphoma clinical trials free to join?
- Study participation is typically free — research sponsors cover the cost of the investigational treatment and study-related visits. Many trials also compensate participants for time and travel. Details vary by study.
- Who can take part in a Hodgkin Lymphoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.